Adverse drug event reporting. Improving the low US reporting rates

Arch Intern Med. 1988 Jul;148(7):1499-503.
No abstract available

MeSH terms

  • Drug-Related Side Effects and Adverse Reactions*
  • Evaluation Studies as Topic* / standards
  • Humans
  • Physician's Role
  • Product Surveillance, Postmarketing* / standards
  • United States
  • United States Food and Drug Administration*